Challenges and Opportunities for Respiratory Syncytial Virus Vaccines

Challenges and Opportunities for Respiratory Syncytial Virus Vaccines-1

Larry J. Anderson • Barney S. Graham
Editors

2013

Responsible series editor: Richard W. Compans

Respiratory syncytial virus (RSV) was first isolated from chimpanzees in 1955, and shortly thereafter from young children, and recognized as an important cause of serious lower respiratory tract disease in infants and young children, i.e., pneumonia and bronchiolitis. Shortly after its discovery efforts to develop a vaccine began. It is now over 50 years since its discovery and no safe and effective vaccine is yet available.

 

Leave a Reply

Your email address will not be published. Required fields are marked *